日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer's disease.

对人类和 3D 细胞模型进行整合通路分析,确定 p38 MAPK-MK2 轴是阿尔茨海默病的一种治疗靶点

Naderi Yeganeh Pourya, Kwak Sang Su, Jorfi Mehdi, Koler Katjuša, Kalatturu Thejesh, von Maydell Djuna, Liu Zhiqing, Guo Kevin, Choi Younjung, Park Joseph, Abarca Nelson, Bakiasi Grisilda, Cetinbas Murat, Sadreyev Ruslan, Griciuc Ana, Quinti Luisa, Choi Se Hoon, Xia Weiming, Tanzi Rudolph E, Hide Winston, Kim Doo Yeon

Cuproptosis Signature Would Reveal the Acute-Remitting Pattern in Patients with Neuromyelitis Optica Spectrum Disorder

铜滴落特征可揭示视神经脊髓炎谱系障碍患者的急性缓解模式

Liu, Peidong; Li, Ruoyu; Wang, Xinlin; Li, Hui; Hu, Huiru; Shen, Ang; Zhu, Wenping; Pan, Jiali; Xing, Yanmeng; Xia, Weiming; Jiao, Henan; Chen, Di; Wu, Lixin; Liu, Li; Liu, Ju; Yu, Bin; Liu, Xianzhi; Liu, Hongbo

Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer's Disease Phenotype in APP/PS1 Transgenic Mice.

PS48(一种 PDK-1 变构激动剂)在 APP/PS1 转基因小鼠中治疗阿尔茨海默病表型的靶点验证研究

Querfurth Henry W, Lemere Cynthia, Ciola Jason, Havas Daniel, Xia Weiming, Lee Han Kyu

Feasibility of Identifying Acute Nontraumatic Intracerebral Hemorrhage Events Using Diagnostic Coding Among Veterans with Mild Cognitive Impairment or Alzheimer's Dementia

利用诊断编码识别轻度认知障碍或阿尔茨海默病痴呆退伍军人急性非创伤性脑出血事件的可行性

Berlowitz, Dan; Wang, Ying; Reisman, Joel; Miller, Donald; Morin, Peter J; Arasa, Vanesa Carlota Andreu; Mittler, Brant; Zhang, Raymond; Tahami Monfared, Amir Abbas; Irizarry, Michael; Zhang, Quanwu; Xia, Weiming

Patient journey and decision processes for anti-amyloid therapy in Alzheimer's disease

阿尔茨海默病抗淀粉样蛋白治疗的患者历程和决策过程

Mittler, Brant; Cambi, Xavier; Biskach, Morgan; Reisman, Joel; Wang, Ying; Berlowitz, Dan; Morin, Peter; Miller, Donald R; Brandao-Viruet, Karla; Clare, Sophie J; Xia, Kevin Z; Tahami Monfared, Amir Abbas; Irizarry, Michael; Zhang, Quanwu; Xia, Weiming

Rock inhibitors in Alzheimer's disease

阿尔茨海默病中的岩石抑制剂

Zheng, Chao; Xia, Weiming; Zhang, Jianhua

Glial fibrillary acidic protein in plasma and intraocular fluids and the correlation with cognitive function in patients with vitreoretinal disease

玻璃体视网膜疾病患者血浆和眼内液中胶质纤维酸性蛋白及其与认知功能的相关性

Ness, Steven; Sampani, Konstantina; Tuz-Zahra, Fatima; Aytan, Nurgul; Alluri, Sreevardhan; Fiorello, Marissa G; Chen, Xuejing; Siegel, Nicole H; Alosco, Michael L; Xia, Weiming; Tripodis, Yorghos; Stein, Thor D; Subramanian, Manju L

Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning

利用机器学习识别血浆蛋白比率以区分阿尔茨海默病患者和健康对照组

Safi, Ali; Giunti, Elisa; Melikechi, Omar; Xia, Weiming; Melikechi, Noureddine

Hypertension a Predictive Risk Factor on Progression to Alzheimer's Disease Using APOEε4 as a Benchmark

以APOEε4为基准,高血压是阿尔茨海默病进展的预测风险因素

Li, Mingfei; Wang, Ying; Kazis, Lewis; Xia, Weiming

Comorbidities and apolipoprotein E genotypes of patients with mild cognitive impairment in transition to Alzheimer's disease

轻度认知障碍患者向阿尔茨海默病过渡阶段的合并症和载脂蛋白E基因型

Li, Mingfei; Wang, Ying; Kazis, Lewis; Weng, Jiaying; Xia, Weiming